Sano blog | public health (2)

public health genetic testing population health

Genetic screening for prevention: Benefits and barriers

Many hereditary diseases are clinically manageable when detected early, yet most carriers are identified only after symptoms appear. Population genomic screenin...

public health rare disease health equity

Newborn screening equity: Sequencing and global gaps

Over the last two decades, following the landmark achievement of sequencing the first complete human genome, a suite of powerful genetic tools has emerged. Gene...

data privacy public health genetic testing

Prenatal genetic testing: NIPT, ethics, and newborn care

Genomic screening is changing how clinicians and families approach prenatal and neonatal care. These tests, which analyze fetal or newborn DNA for chromosomal c...

thought leadership public health genetic testing

Newborn genome sequencing: Clinical and ethical perspectives

In a webinar hosted by Dr. Patrick Short, CEO of Sano Genetics, and featuring Dr. Wendy Chung, Dr. Holly Peay, and Kira Dineen, panelists explored recent develo...

public health genetic testing health equity

Genomic literacy and health disparities in genetic research

Genetics now shapes how medicines are developed, how patients are diagnosed, and how clinical decisions are made. Yet a persistent gap exists between the pace o...

precision medicine public health health equity

Cultural competence in genomic medicine

Genetic variation across populations has direct consequences for precision medicine trial design. As patient populations in clinical research become more ethnic...

public health genetic testing health equity

Towards inclusive health: Bridging genomic data and equity in healthcare

Health equity, defined as everyone having the opportunity to be as healthy as possible, has long been a primary goal of public health. Still, across the world, ...

genetic epidemiology public health

COVID-19 and genomic sequencing: Tracking variants and lessons for future pandemics

As COVID-19 continues to affect us all, it has become evident that our fight against the virus is not just about developing vaccines and therapeutics. Equally c...

long covid insights report social graphic

genetic epidemiology industry report public health

The long haul: How long COVID continues to challenge healthcare

Long COVID, affecting nearly 28% of COVID-19 survivors, is a multifaceted condition that extends well beyond its initial impact. Typical include fatigue, concen...

public health health equity

The history of women in clinical trials

Clinical trials are the foundation of modern medicine. They determine which treatments reach patients and how those treatments are understood. Yet for much of h...

Clinical research blog